University of Washington School of Public Health and Community Medicine Biostatistics ChairAppointed: 1984 University of Washington School of Public Health and Community Medicine Biostatistics ProfessorAppointed: 1984 Fred Hutchinson Cancer Research Center Public Health Sciences Division | |
QualificationsPh.D., University of Maryland, 1976. M.A., 1974. Expertise and Research InterestsMy expertise is in the following areas: survival analysis; cancer clinical trials; AIDS research; sequential analysis.
KeywordsCOS Keywords:AIDS, Cancer Or Carcinogenesis, Clinical Trial.Additional Terms:AIDS Research, Cancer Clinical Trials, Sequential Analysis, Survival Analysis.Publications- Psaty BM, Weiss NS, Furberg CD, Koepsell TD, Siscovick DS, Rosendaal FR, Smith NL, Heckbert SR, Kaplan RC, Lin D, Fleming TR, Wagner EH, Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease., JAMA, 282(8), 786-90, 25 Aug 1999
 - Fleming TR, Issues in the design of clinical trials: insights from the trastuzumab \(Herceptin\) experience., Seminars in Oncology, 26(4 Suppl 12), 102-7, August 1999
 - Schaper C, Fleming TR, Self SG, Rida WN, Statistical issues in the design of HIV vaccine trials., Annual Review of Public Health, 16, 1-22, 1995
 - Fleming TR, Neaton JD, Goldman A, DeMets DL, Launer C, Korvick J, Abrams D, Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS., Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10 Suppl 2, S9-18, 1995
 - Fleming TR, Prentice RL, Pepe MS, Glidden D, Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research., Stat Med, 13(9), 955-68, 15 1994

Profile DetailsIndividual Expertise profile of Thomas Richard Fleming, Copyright Thomas Richard Fleming. © COS Expertise TM, 2009, ProQuest LLC All rights reserved. |